The document summarizes the interaction of four interlinked physiological systems - the kinin system, clotting system, fibrinolytic system, and complement system. These systems are activated by factor XII and their end products further activate each other, resulting in increased vascular permeability, smooth muscle contraction, vasodilation, and other inflammatory responses. The kinin system generates bradykinin, the clotting system forms fibrin, the fibrinolytic system produces plasmin and fibrin split products, and the complement system yields anaphylatoxins and activates phagocytosis.
A power point presentation on "Drugs affecting coagulation and anticoagulants" suitable for undergraduate medical students. Also suitable for Post Graduate students of Pharmacology and Pharmaceutical Sciences.
in this presentation i have tried to briefly discuss about diuretics (water pills), their classification, mechanism of action, pharmacokinetics and pharmacodynamics of these drugs
This presentation is for those who want to understand the basics of reversible cell injury.
You can also get more idea from my youtube channel:
Harshit Jadav I Medical Wala
Pharmacokinetics - drug absorption, drug distribution, drug metabolism, drug ...http://neigrihms.gov.in/
A power point presentation on general aspects of Pharmacokinetics suitable for undergraduate medical students beginning to study Pharmacology. Also suitable for Post Graduate students of Pharmacology and Pharmaceutical Sciences.
Autacoids - pharmacological actions and drugs related to them. SIVASWAROOP YARASI
Autacoids or "autocoids" are biological factors which act like local hormones, have a brief duration, and act near the site of synthesis. The word autacoids comes from the Greek "autos" (self) and "acos" (relief, i.e. drug).
A power point presentation on "Drugs affecting coagulation and anticoagulants" suitable for undergraduate medical students. Also suitable for Post Graduate students of Pharmacology and Pharmaceutical Sciences.
in this presentation i have tried to briefly discuss about diuretics (water pills), their classification, mechanism of action, pharmacokinetics and pharmacodynamics of these drugs
This presentation is for those who want to understand the basics of reversible cell injury.
You can also get more idea from my youtube channel:
Harshit Jadav I Medical Wala
Pharmacokinetics - drug absorption, drug distribution, drug metabolism, drug ...http://neigrihms.gov.in/
A power point presentation on general aspects of Pharmacokinetics suitable for undergraduate medical students beginning to study Pharmacology. Also suitable for Post Graduate students of Pharmacology and Pharmaceutical Sciences.
Autacoids - pharmacological actions and drugs related to them. SIVASWAROOP YARASI
Autacoids or "autocoids" are biological factors which act like local hormones, have a brief duration, and act near the site of synthesis. The word autacoids comes from the Greek "autos" (self) and "acos" (relief, i.e. drug).
A lecture on Chemical Mediators of inflammation as a part of undergraduate pathology curriculum. The lecture is primarily based on Robbin's textbook of pathology
Plasma cell disorders is a difficult topic where most residents and students confuse with regarding to differentiating between various types of para-proteinemias or plasma cell dyscrasias. This simple presentation will highlight the key points in differentiating, diagnosing these orders. Initial management principles are discussed as well.
This e book in pdf format will serve as a rapid reference book for undergraduate and postgraduate students of pathology during pathology practical classes and also during exams.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
2. THESE INCLUDE VARIOUS PRODUCTS DERIVED FROM
ACTIVATION AND INTERACTION OF 4 INTERLINKED
SYSTEMS
1)Kinin
2)Clotting
3)Fibrinolytic and Complement
EACH OF THESE SYSTEMS HAS ITS INHIBITORS AND ACCELERATORS
IN PLASMA WITH NEGATIVE AND POSITIVE FEEDBACK
MECHANISMS.....
3. INTRODUCTION
HAGEMAN FACTORS(FACTOR xii) OF CLOTTING SYSTEM
PLAYS A KEY ROLE IN INTERACTIONS OF FOUR
SYSTEMS.ACTIVATION OF FACTOR XII IN VIVO BY
CONTACT WITH BASEMENT MAMBRRANEAND BACTERIAL
ENDOTOXINS AND IN VITRO WITH GLASS OR KAOLIN
LEADS TO ACTIVATION OF CLOYYING,FIBRINOLYTIC AND
KININ SYSTEMS. IN INLAMMATION ACTIVATION OF
FACTORXII IS BROUGHT ABOUT BY CONTACT OF THE
FACTOR LEAKING THROUGH THE ENDOTHELIAL
GAPS.THE END PRODUCTS OF THE
CLOTTING,FIBRINOLYTIC AND KININ SYSTEM ACTIVATE
THE COMPLEMEMTSYSTEM THAT GENETRATE
PERMEABILITY FACTORS,IN TURN,FURTHER ACTIVATES
CLOTTING SYSTEM.
4. FACTOR XII
FACTOR XIIa
FIBRIONOLYTIC CLOTTING KININ SYSTEM
SYSTEM SYSTEM
PLASMIN FIBRIN BRADYKININ
FIBRIN SPLIT
PRODUCTS
COMPLEMENTARY SYSTEM PERMEABILITY
FACTORS
5. I)THE KININ SYSTEM
THIS SYSTEM ON ACTIVATION BY FACTOR XIIa
GENETRATES BRADYKININ ,SO NAMED BECAUSE
OF SMOTH MUSCLE IT INDUCES.FIRST
KALLIKREIN IS FORMED FROM PREKALLILREIN BY
THEACTION OF PREKALLIKREIN WHICH IS A
FRAGMENT OF FACTOR XIIa KALLIKREIN THEN
ACTS ON HIGH MOLECULAR WEIGHT KININOGEN
TO FORM BRADYKININ.BRADYKININ ACTS IN THE
EARLY STAGE AND ITS EFFECTS INCLUDE:
1. SMOOTH MUSCLE CONTACTION
2. VASODIALATION
3. INCREASED VASCULAR PERMEABILITY
4. PAIN
6. II)THE CLOTTING SYSTEM
FACTOR XIIa initiates the clotting cascade of the
clotting system resulting in formation of
fibrionogenwhich is acted upon by thrombin to form
fibrin and fibrinopeptides the actions of
fibrionopeptides in inflammtion are:
1. Increased vascular permeability
2. Chemotaxis for leucocyte
3. And anti coagulant activity
7. III)THE FIBRINOLYTIC SYSTEM
THIS SYSTEM IS ACTIVATED BY PLASMINOGEN ACTIVATOR THE SOURCE OF
WHICH INCLUDEKALLIKREIN OF THE KININ SYSTEM,ENDOTHELIAL CELLS
AND LEUCOCYTES.PLASMINOGEN ACTIVATOR ACTS ON PLASMINOGEN
PRRESNT AS COMPONENT OF PLASMA PROTEINS TO FORM PLASMIN.
FURTHER BREAKDOWN OF FIBRIN BY PLASMA FORMS FIBRINOPEPTIDES OR
FIBRIN SPLIT PRODUCTS
THE ACTIONS OF PLASMIN IN INFLAMMTION ARE-
1. ACTIVATION OF FACTOR XII TO FORM PREKALLIKREIN ACTIVATOR THAT
STIMULATES THE KININ SYSTEM TO GENERATE BRADYKININ;
2. SPLITS OFF COMPLEMENT C3 TO FORM C3a WHICH IS A PERMEABILITY
FACTOR;
3. DEGRADES FIBRIN TO FORM FIBRIN SPLIT PRODUCTS WHICH INCREASE
VASCULAR PERMEABILITY AND ARE CHEMOTACTIC TO LEUCOCYTES.
8. IV)THE COMPLEMENT SYSTEM
THE ACTIVATION OF COMPLEMENT SYSTEM CAN OCCUR
EITHER;
1)BY CLASSIC PATHWAY THROUGH ANTIGEN-ANTIBODY COMPLEX
2) BY ALTERNATE PATHWAY VIA NON-IMMUNOLOGIC AGENTS SUCH
AS BACTERIAL TOXINS,COBRA VENOMS AND IgA.
COMPLEMENT SYSTEM ON ACTIVATION BY EITHER OF THESE
TWO PATHWAYS YIELDS ANAPHYLATOXINS C3a,C4a AND C5a AND
MEMBRANE ATTACK COMPLEX(MAC).
THE RELATIVE POTANCIES OF ANAPHYLATOXINS ARE IN
DESCENDING SEQUENCE OF C3a,c5a AND C4a
9. THE ACTION OF ANAPHYLATOXINS IN INFLAMMATAION ARE;
1. RELEASE OF HISTAMINE FROM MAST CELLS AND BASOPHILLS;
2. INCRESEAD VASCULAR PERMEABILITY CAUSING OEDEMA IN TISSUES
3. C3b AUGMENTS PHAGOCYTOSIS AND
4. C5a IS CHEMOTACTIC FOR LEUCOCYTES
THE ACTION OF MAC IS TO CAUSE PORES IN THE CELL MEMBRANE OF
THE INVADING MICROORGANISM